Transparency: OpenBeam X is currently in formation. We are recruiting partners and advisors for a pilot phase and governance build-out.

Precision for everyone, everywhere.

Status: OpenBeam X is currently in formation. We are preparing to establish a public-good standards organisation and to build an open stereotactic guidance framework so that any linear accelerator can deliver safe, precise SRS/SBRT using EPID + AI—without new CBCT hardware.

Mission

Our mission is to eliminate hardware cost as a barrier to high-precision radiotherapy. We are organising a public-good effort to create an open global standard so hospitals—from community sites in the US/EU to LMIC centres—can activate stereotactic capability on the existing installed base of LINACs.

~16,000RT machines worldwide
>60%lack volumetric IGRT
0$software cost for LMICs

What we’re developing

  • OpenBeam X Foundation (in formation): a nonprofit vehicle to steward an open stereotactic guidance standard.
  • PrecisionGrid Engine (proposed): an AI reference implementation that turns EPID + log files into synthetic 3D geometric certainty.
  • Certification & QA (planned): enterprise-grade audits, safety documentation, and training for systems that need liability assurance.

Why EPID‑AI?

  • Continuous in‑beam feedback (not a single pre‑beam snapshot)
  • Zero additional imaging dose
  • Couch‑agnostic (works with standard 3‑DOF couches)
  • Stronger online adaptation potential than CBCT

Equity model (intended)

We intend to keep the core software open and free for LMICs. High-income systems would pay only for certification, QA audits, and integration support. This design guarantees access while sustaining the work.

For partners

  • WHO/IAEA alignment for national deployments
  • Hospital networks & refurb channels welcome
  • Society collaborations (ASTRO/ESTRO/AAPM)
\n

Prefer a hosted form? Replace this with a Formspree action URL later.

Contact

Email: ahmedgalal_md@yahoo.com

We welcome collaborators in AI/ML, medical physics, health systems, and global oncology policy.